A 62-year-old man presents to his primary care physician because of progressive weight loss and worsening abdominal discomfort. He has a 15-year history of chronic pancreatitis attributed to alcohol use disorder. Over the years, he has developed pancreatic exocrine insufficiency requiring pancreatic enzyme replacement therapy and insulin-dependent diabetes mellitus. During the past 4 months, he has unintentionally lost 18 pounds despite adherence to enzyme supplementation. He also reports worsening epigastric pain radiating to the back.
Vital signs are normal. Physical examination reveals a thin man with mild epigastric tenderness. Laboratory studies demonstrate the following:
CT scan of the abdomen demonstrates a 3.5-cm mass in the head of the pancreas.
Which of the following is the most likely explanation for this patient’s current condition?
The correct answer is:
A) Development of pancreatic adenocarcinoma
This patient has chronic pancreatitis and now presents with several concerning features that suggest pancreatic adenocarcinoma: progressive weight loss, worsening back pain, cholestatic liver enzyme abnormalities, and a pancreatic head mass on imaging. Chronic pancreatitis is an established risk factor for pancreatic cancer, particularly in patients with longstanding disease.
Pancreatic adenocarcinoma often presents insidiously. Common symptoms include unexplained weight loss, abdominal pain radiating to the back, anorexia, and new or worsening diabetes mellitus. Tumors located in the head of the pancreas may obstruct the common bile duct, leading to jaundice and a cholestatic pattern of liver enzyme elevation, as seen in this patient.
One of the major educational points for Step 2 is distinguishing the expected manifestations of chronic pancreatitis from findings that should raise concern for malignancy. Chronic pancreatitis commonly causes chronic abdominal pain, diabetes, and steatorrhea. However, a significant change in symptoms, especially progressive weight loss, worsening pain, jaundice, or a newly identified pancreatic mass, should prompt evaluation for pancreatic cancer.
The risk of pancreatic adenocarcinoma is significantly increased in patients with chronic pancreatitis due to longstanding inflammation and fibrosis. This relationship is frequently tested because students may incorrectly attribute new symptoms entirely to chronic pancreatitis rather than recognizing a serious complication.
Answer choice B: Progression of pancreatic exocrine insufficiency alone, is incorrect.
Exocrine insufficiency causes steatorrhea, malabsorption, and weight loss. However, it does not explain the pancreatic mass or the cholestatic liver enzyme abnormalities. The development of jaundice and a pancreatic head lesion strongly suggests malignancy.
Answer choice C: Recurrent acute pancreatitis, is incorrect.
Acute pancreatitis typically presents with abrupt onset of severe epigastric pain and elevated pancreatic enzymes. It would not explain the persistent weight loss, biliary obstruction, and pancreatic mass.
Answer choice D: Small intestinal bacterial overgrowth, is incorrect.
Small intestinal bacterial overgrowth (SIBO) can cause bloating, diarrhea, and malabsorption. However, it would not cause obstructive jaundice or a pancreatic mass and therefore cannot account for this patient’s overall presentation.
Answer choice E: Zollinger-Ellison syndrome, is incorrect.
Zollinger-Ellison syndrome results from a gastrin-secreting neuroendocrine tumor and is characterized by refractory peptic ulcer disease and chronic diarrhea. It does not typically present with obstructive jaundice and a pancreatic head mass in a patient with longstanding chronic pancreatitis.
Key Learning Point
Longstanding chronic pancreatitis is a risk factor for pancreatic adenocarcinoma. New symptoms such as progressive weight loss, worsening abdominal pain, obstructive jaundice, or a pancreatic mass should prompt evaluation for malignancy rather than being attributed solely to chronic pancreatitis.
